66 results match your criteria: "centre hospitalier public du Cotentin[Affiliation]"

Diagnosis and management of head and neck cancers in a high-incidence area in France: A population-based study.

Medicine (Baltimore)

June 2017

Registre général des tumeurs du Calvados, Centre F Baclesse, U1086 Inserm - Université Caen Basse Normandie "Cancers et preventions," av Général-Harris, Caen Pôle de Recherche, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, "Cancers et préventions", Centre F Baclesse, av Général-Harris, Caen U1086 Inserm - Université Caen Basse Normandie Registre des cancers de la Manche, Centre Hospitalier Public du Cotentin, Cherbourg-Octeville Registre du cancer de la Somme, Hôpital Nord, CHU Amiens, Place Victor Pauchet, Amiens Service ORL et chirurgie cervico-faciale, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, "Cancers et préventions", Centre F Baclesse, av Général-Harris, Caen Registre général des cancers de Lille et sa région, GCS Centre de Référence Régional en Cancérologie, CHRU de LILLE - Hôpital Calmette, Boulevard du Professeur Jules Leclercq, Lille, France.

Head and neck cancers have a very poor prognosis and are common in France. They are subject to various recommendations for early detection and management, but there is no detailed data in the French general population to fuel the public health debate on it.A high-resolution population-based study about cancer management was conducted, using cancers registries in the north-west of France, on 1729 tumors diagnosed between 2008 and 2010.

View Article and Find Full Text PDF

Background: The ZOHé study was a prospective, observational, multicenter study in France to assess use of biosimilar filgrastim Zarzio in routine clinical practice in patients undergoing neutropenia-inducing chemotherapy.

Patients And Methods: Patients ≥ 18 years undergoing chemotherapy for a malignant disease and with a first prescription for Zarzio were enrolled in 2 cohorts: solid tumor (1174 patients) or hematological malignancy (633 patients); the latter is reported here. Analyses primarily described the prescription and use of Zarzio in current practice, and included identification of factors linked to prescription for primary prophylaxis, comparison of use in relation to European Organisation for the Research and Treatment of Cancer (EORTC) guidelines, and estimation of chemotherapy dose intensity maintenance in patients given Zarzio.

View Article and Find Full Text PDF

Pheochromocytoma Crisis in the ICU: A French Multicenter Cohort Study With Emphasis on Rescue Extracorporeal Membrane Oxygenation.

Crit Care Med

July 2017

1Service de Réanimation Médicale Polyvalente, Centre Hospitalier Public du Cotentin, Cherbourg-en-Cotentin, France.2Service de Réanimation Médicale, Centre Hospitalier Universitaire, Avenue de la Côte de Nacre, Caen, France.3Service de Réanimation Médicale et Médecine hyperbare, Centre Hospitalier Universitaire, Angers, France.4Service de Réanimation Médicale, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.5Service d'Anesthésie Réanimation, Groupement des Hôpitaux de l'Institut Catholique de Lille, Lille, France.6Service de Réanimation Chirurgicale, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.7Service de Réanimation Médico-chirurgicale, Centre Hospitalier Universitaire Dupuytren, Limoges Cedex, France.8Département d'Anesthésie-Réanimation, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.9Service de Réanimation Médicale et infectieuse, Hôpital Bichat Claude Bernard, Assistance Publique-Hôpitaux de Paris, Paris, France.10Service de Réanimation Médicale, Centre Hospitalier Universitaire, Rouen, France.11Service de Réanimation Médico-chirurgicale, Centre Hospitalier de Longjumeau, Longjumeau, France.12Service de Réanimation Médicale, Hôpital Brabois, Centre Hospitalier Universitaire, Vandoeuvre les Nancy, France.13Service de Réanimation Polyvalente, Hôpital Félix-Guyon, Centre Hospitalier Universitaire, Saint-Denis, La Réunion, France.14Service de Réanimation Polyvalente, Centre Hospitalier de Cholet, Cholet Cedex, France.15Service de Réanimation Polyvalente, Centre Hospitalier Robert Ballanger, boulevard Robert Ballanger, Aulnay sous Bois, France.16Service de Réanimation Polyvalente, Centre Hospitalier Versailles, Le Chesnay, France.17Service de Médecine intensive, Centre Hospitalier Marc Jacquet, Melun cedex, France.18Service d'Anesthésie Réanimation, Centre Hospitalier Universitaire, Caen, France.19Université de Caen Normandie, Esplanade de la Paix, Caen, France.20Service de Réanimation Médicale, CHU Grenoble Alpes, Grenoble, France.

Objectives: To describe the characteristics, management, and outcome of patients admitted to ICUs for pheochromocytoma crisis.

Design: A 16-year multicenter retrospective study.

Setting: Fifteen university and nonuniversity ICUs in France.

View Article and Find Full Text PDF

Development of a model to predict the 10-year cumulative risk of second primary cancer among cancer survivors.

Cancer Epidemiol

April 2017

Registre des cancers du Bas-Rhin, Laboratoire d'Épidémiologie et de Santé Publique, EA3430, FMTS, Université de Strasbourg, 4 rue Kirschleger, 67085 Strasbourg CEDEX, France; Service de Santé Publique, Hôpitaux Universitaires de Strasbourg, 1 place de l'hôpital, 67091 Strasbourg CEDEX, France; Francim: Réseau français des registres des cancers, 31073 Toulouse, France. Electronic address:

Background: To develop a prediction model to quantify the cumulative risk of Second Primary Cancer (SPC) among cancer patients given that they survive their disease.

Methods: A cohort of 293,435 patients based on data from twelve French cancer registries was analyzed. For five first cancer sites, SPC incidence rates were estimated using Poisson regression models.

View Article and Find Full Text PDF

[Vaginal adenosis: A case report and literature review].

Ann Pathol

August 2016

Service d'anatomie pathologique, centre François-Baclesse, 3, avenue du Général-Harris, 14000 Caen, France; Service d'anatomie pathologique, centre hospitalier Public du Cotentin, 46, rue du Val-de-Saire, 50100 Cherbourg-Octeville, France.

We report a case of vaginal adenosis in a woman of 42years. This is a rare congenital disorder since cessation of use of diethylstilbestrol (DES), usually of benign course, not to ignore in its tubo-endometrial histological form which may progress to atypical adenosis precursor of vaginal clear cell adenocarcinoma in patients exposed in utero to DES.

View Article and Find Full Text PDF

Early MRI in neonatal hypoxic-ischaemic encephalopathy treated with hypothermia: Prognostic role at 2-year follow-up.

Eur J Radiol

August 2016

CHU Rennes, Department of Paediatric Radiology, Hôpital Sud, 16 Boulevard de Bulgarie, 35200 Rennes, France.

Unlabelled: The prognostic role of early MRI (≤ 6 days of life) is still uncertain in hypoxic-ischaemic encephalopathy (HIE) treated with hypothermia.

Objective: To compare the prognostic value of early (≤ 6 days) and late MRIs (≥ 7 days) in predicting adverse outcome at 2 years old in asphyxiated term neonates treated with hypothermia.

Methods: This retrospective study included all asphyxiated neonates eligible for hypothermia treatment between November 2009 and July 2012.

View Article and Find Full Text PDF

Background: Elevation of the immature/total granulocyte (I/T-G) ratio has been reported after out-of-hospital cardiac arrest (OHCA). Our purpose here was to evaluate the prognostic significance of the I/T-G ratio and to investigate whether the I/T-G ratio improves neurological outcome prediction after OHCA.

Methods: This single-center prospective cohort study included consecutive immunocompetent patients admitted to our intensive care unit over a 3-year period (2012-2014) after successfully resuscitated OHCA.

View Article and Find Full Text PDF

Background: In the context of early detection of head and neck cancers (HNC), the aim of this study was to describe how people sought medical consultation during the year prior to diagnosis and the impact on the stage of the cancer.

Methods: Patients over 20 years old with a diagnosis of HNC in 2010 were included from four French cancer registries. The medical data were matched with data regarding uptake of healthcare issued from French National Health Insurance General Regime.

View Article and Find Full Text PDF

What are the real waiting times for therapeutic management of head and neck cancer: a study in the general population in the north-west of France.

Eur Arch Otorhinolaryngol

November 2016

Registre général des cancers de Lille et sa région, GCS "Centre de Référence Régional en Cancérologie", CHRU de LILLE, Hôpital Calmette, Pavillon Breton, Boulevard du Professeur Jules Leclercq, 59037, Lille Cedex, France.

Head and neck cancers (HNC) have a poor prognosis and a long treatment delay may have a negative impact on this. Some studies have investigated the determinants of this delay but not in the general population and rarely taking into account socio-economic factors. A high-resolution population-based study about cancer management was conducted, using registries in the north-west of France, on HNC diagnosed between 2008 and 2010.

View Article and Find Full Text PDF

Background. In a French large population-based case-control study we investigated the dose-response relationship between lung cancer and occupational exposure to diesel motor exhaust (DME), taking into account asbestos exposure. Methods.

View Article and Find Full Text PDF

Purpose: Chemotherapy-induced nausea and vomiting (CINV) still remain frequent. The procedure for announcing the diagnosis (PAD) was an emblematic measure of the first French Plan Cancer aiming at providing patients with time to listen, information after cancer diagnosis, and discussion on treatments and their side effects. We aimed at assessing the risk factors of CINV, focusing on patients' satisfaction with the PAD.

View Article and Find Full Text PDF

Objectives: In advanced non-small cell lung cancer (NSCLC), maintenance therapy has emerged as a novel therapeutic reference for patients with non-progressive disease after platinum-based induction chemotherapy. However, the use of double maintenance (DM) with pemetrexed and bevacizumab is still being evaluated in terms of its clinical benefits and safety profile. The objective of this retrospective study was to describe the reasons for DM discontinuation in a real-world setting.

View Article and Find Full Text PDF

Effect of previous history of cancer on survival of patients with a second cancer of the head and neck.

Oral Oncol

May 2015

Registre des cancers du Bas-Rhin, Laboratoire d'Épidémiologie et de Santé Publique, EA3430, FMTS, Université de Strasbourg, 4 rue Kirschleger, 67085 Strasbourg CEDEX, France; Service de santé publique, Hôpitaux Universitaires de Strasbourg, 1 place de l'hôpital, 67091 Strasbourg CEDEX, France; Service d'épidémiologie et de biostatistique, Centre Paul Strauss, 3 rue de la Porte de l'hôpital, 67065 Strasbourg CEDEX, France; Francim: Réseau français des registres des cancers, Toulouse F-31073, France.

Objective: To provide head and neck squamous cell carcinoma (HNSCC) survival estimates with respect to patient previous history of cancer.

Materials And Methods: Data from ten French population-based cancer registries were used to establish a cohort of all male patients presenting with a HNSCC diagnosed between 1989 and 2004. Vital status was updated until December 31, 2007.

View Article and Find Full Text PDF

Non-Hodgkin lymphoma (NHL) represents a heterogeneous group of diseases that are known to carry a considerable risk of second primary cancer (SPC). However, little attention has been paid to SPC risk assessment according to NHL subtypes. Data from 10 French population-based cancer registries were used to establish a cohort of 7546 patients with a first diagnosis of NHL (eight subtypes) between 1989 and 2004.

View Article and Find Full Text PDF

[Feasibility between AN69 and hemodiafiltration online].

Nephrol Ther

February 2010

Service de néphrologie hémodialyse, centre hospitalier public du Cotentin, BP208, Cherbourg cedex, France.

Removal of the middle molecules (MM) weight toxins, and particularly of beta-2-microglobuline (b2M) is made first by convection technique with membranes habitually used in hemodiafiltration online (HDFOL). AN69 was in standard hemodialysis (HD) the reference membrane for the removal of b2M mostly (60%) by adsorption. Its use with convective methods is generally restricted to low efficiency modalities with low substitution rates (Qs), either with continuous HF or HDF for acute renal failure, or with acetate free biofiltration (AFB) for chronic renal failure.

View Article and Find Full Text PDF

[Dysphagia in an elderly demented woman].

Presse Med

February 2008

Service de soins de suite et réadaptation, Centre hospitalier public du Cotentin, Hôpital de Valognes, F-50700 Valognes, France.

View Article and Find Full Text PDF